Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations
To understand the pathogenesis of DNMT3A in acute monocytic leukemia (AML-M5), we identified genes that are expressed differently in leukemia cells from AML-M5 patients collected at diagnosis with DNMT3A mutations (6 cases) compared to those without the mutations (4 cases). Differences of expression...
ORGANISM(S): Homo sapiens 
2011-02-12 | E-GEOD-27187 | biostudies-arrayexpress
TranscriptomicsNormalization of whole-genome SNP data from acute monocytic leukemia patients for exome sequencing
With the whole genome SNPs array information, we could evaluate the sensitivity and specificity of the point mutation we conclude from the next-generation sequencing data. Furthermore, we could use the true positive mutation as our guidance to exclude the most unreliable single nucleotide variation...
ORGANISM(S): Homo sapiens 
2011-02-12 | E-GEOD-27193 | biostudies-arrayexpress
Genomicsena-DATASET-TAU-03-04-2017-19:28:40:078-460 - samples
Targeted resequencing of samples was done with TruSeq custom amplicon low input kit (TSCA-LI, Illumina). The oligo capture probes were designed to include a prefix of 8 random nucleotides at the 5 end of each probe. The assay is designed such that each targeted locus is annealed with two probes, res...
EGAD00001003275 | EGA
Genomicsena-DATASET-TAU-08-04-2017-14:02:11:924-149 - samples
Description not provided
EGAD00001003280 | EGA
GenomicsSuppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down Syndrome
Children with Down Syndrome (DS) are prone to development of high risk B-cell precursor ALL (DS-ALL) that differs genetically from most sporadic pediatric ALLs. Increased expression of CRLF2, the receptor to thymic stromal lymphopoietin (TSLP) characterizes about half of DS-ALLs and also a subgroup ...
EGAS00001002410 | EGA
GenomicsDAC for data acquired during the Down Syndrome acute lymphoblastic leukemia project. The project was performed with clinical samples of the AIEOP-BFM trial.
Data Access Committee EGAC00001000644
EGAC00001000644 | EGA
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
Sort   by:  
 Page size